Atea Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $319k | 95k | 3.35 |
| 2024-06-30 | $153k | 46k | 3.31 |
| 2024-03-31 | $417k | 103k | 4.04 |
| 2023-12-31 | $209k | 68k | 3.05 |
| 2023-09-30 | $205k | 68k | 3.00 |
| 2023-06-30 | $235k | 63k | 3.74 |
| 2023-03-31 | $12k | 3.8k | 3.27 |
| 2022-12-31 | $1.0M | 210k | 4.80 |
| 2022-06-30 | $267k | 45k | 5.99 |
| 2022-03-31 | $1.6M | 220k | 7.23 |
| 2021-12-31 | $410k | 46k | 8.93 |
| 2021-03-31 | $507k | 8.2k | 61.79 |
| 2020-12-31 | $1.6M | 39k | 41.77 |